The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study

BACKGROUND: Tuberculosis (TB) is preventable and curable but eliminating it has proven challenging. Safe and effective TB vaccines that can rapidly reduce disease burden are essential for achieving TB elimination. We assessed future costs, cost-savings, and cost-effectiveness of introducing novel TB...

Descripción completa

Detalles Bibliográficos
Autores principales: Portnoy, Allison, Clark, Rebecca A., Quaife, Matthew, Weerasuriya, Chathika K., Mukandavire, Christinah, Bakker, Roel, Deol, Arminder K., Malhotra, Shelly, Gebreselassie, Nebiat, Zignol, Matteo, Sim, So Yoon, Hutubessy, Raymond C. W., Baena, Inés Garcia, Nishikiori, Nobuyuki, Jit, Mark, White, Richard G., Menzies, Nicolas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873163/
https://www.ncbi.nlm.nih.gov/pubmed/36693081
http://dx.doi.org/10.1371/journal.pmed.1004155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873163/
https://www.ncbi.nlm.nih.gov/pubmed/36693081
http://dx.doi.org/10.1371/journal.pmed.1004155

Ejemplares similares